Compound in grapes, red wine could be key to fighting prostate cancer
Resveratrol, a compound found commonly in grape skins and red wine, has been shown to have several beneficial effects on human health, including cardiovascular health and stroke prevention. Now, a University ...
Cancer
Nov 10, 2012 |
5 / 5 (6) |
5
|
Sickle cells show potential to attack aggressive cancer tumors
By harnessing the very qualities that make sickle cell disease a lethal blood disorder, a research team led by Duke Medicine and Jenomic, a private cancer research company in Carmel, Calif., has developed ...
Cancer
Jan 09, 2013 |
5 / 5 (4) |
0
|
Scientists find new gene markers for cancer risk
A huge international effort involving more than 100 institutions and genetic tests on 200,000 people has uncovered dozens of signposts in DNA that can help reveal further a person's risk for breast, ovarian ...
Genetics
Mar 27, 2013 |
5 / 5 (4) |
1
Cloned receptor paves way for new breast and prostate cancer treatment
Researchers at Uppsala University have cloned a T-cell receptor that binds to an antigen associated with prostate cancer and breast cancer. T cells that have been genetically equipped with this T-cell receptor have the ability ...
Cancer
Sep 13, 2012 |
4 / 5 (4) |
0
|
Test developed to detect early-stage diseases with naked eye
Scientists have developed a prototype ultra-sensitive sensor that would enable doctors to detect the early stages of diseases and viruses with the naked eye, according to research published today in the journal Nature Na ...
Cancer
Oct 28, 2012 |
5 / 5 (3) |
0
|
New genetic test can predict man's risk of developing prostate cancer
Researchers in Japan have created a genetic test that will help doctors diagnose prostate cancer. When given together with testing for prostate specific antigen (PSA), a widely used diagnostic biomarker for ...
Cancer
Feb 08, 2013 |
5 / 5 (3) |
0
|
Virus shows promise as prostate cancer treatment
A recombinant Newcastle disease virus kills all kinds of prostate cancer cells, including hormone resistant cells, but leaves normal cells unscathed, according to a paper published online ahead of print in the Journal of ...
Cancer
Feb 25, 2013 |
5 / 5 (3) |
0
|
Researchers find cancer aggression differences in different types of prostate cells
(Medical Xpress)—A research team made up of representatives from several cancer research centers in the United States has found that cancers that develop in the prostate of mice may be either aggressive or sluggish depending ...
Cancer
Feb 25, 2013 |
4.7 / 5 (3) |
0
|
Treatment for painful curved penis shows promise
(HealthDay)—Some diseases are especially tough to discuss. When Tony Lee realized that his penis was curving whenever he had an erection—making it painful and difficult for him to have sex—he had no ...
Diseases, Conditions, Syndromes
May 08, 2013 |
4.7 / 5 (3) |
0
Blood thinners may boost survival for prostate cancer patients
(HealthDay)—Men with advanced prostate cancer might live longer when they are taking blood-thinning medication, a small study suggests.
Cancer
Feb 21, 2013 |
3.7 / 5 (3) |
0
Discovery opens door for breast, prostate cancer treatments
(Medical Xpress)—A team of Western Australian cancer researchers interested in the strong link between hormones and cancer have discovered three new molecules that may have an important role to play in ...
Cancer
Apr 22, 2013 |
3.7 / 5 (3) |
0
|
Epigenetic causes of prostate cancer
(Medical Xpress)—In about half of all prostate tumours, there are two genetic areas that are fused with one another. When this is not the case, the exact way cancer cells originate in prostate tumours was not clear until ...
Cancer
Sep 05, 2012 |
5 / 5 (2) |
0
Prostate cancer: Curcumin curbs metastases
Powdered turmeric has been used for centuries to treat osteoarthritis and other illnesses. Its active ingredient, curcumin, inhibits inflammatory reactions. A new study led by a research team at Ludwig-Maximilians-Universität ...
Cancer
Oct 12, 2012 |
5 / 5 (2) |
0
|
Prostate cancer prognosis hope
Cancer of the prostate – the most common male cancer in the UK – presents in two distinct ways: a low-risk type, which may never cause any symptoms, and a high-risk form that needs treatment to prevent it spreading to ...
Cancer
Oct 29, 2012 |
5 / 5 (2) |
0
|
Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
Mayo Clinic has received U.S. Food and Drug Administration approval to produce and administer Choline C 11 Injection, an imaging agent used during a positron emission tomography (PET) scan to help detect sites of recurrent ...
Cancer
Nov 08, 2012 |
5 / 5 (2) |
0
